The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
MarcosPereira;
Enny Paixão ;
AneteTrajman;
Ramon Andradede Souza;
Marcio Santosda Natividade;
Julia M Pescarini ;
Susan MartinsPereira;
Florisneide RodriguesBarreto;
RicardoXimenes;
MargarethDalcomo;
+4 more...
Maria YuryIchihara;
CeuciNunes;
ManoelBarral-Netto;
Maurício LBarreto;
(2020)
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.
RESPIRATORY RESEARCH, 21 (1).
178-.
ISSN 1465-9921
DOI: 10.1186/s12931-020-01439-4
Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.
Item Type | Article |
---|---|
Elements ID | 150968 |
Downloads
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
Find work associated with the research centre(s):
Find work from this publication:
ORCID: https://orcid.org/0000-0002-4797-908X
ORCID: https://orcid.org/0000-0001-8711-9589